Details for Patent: 9,555,023

Which drugs does patent 9,555,023 protect, and when does it expire?

Patent 9,555,023 protects BEVYXXA and is included in one NDA.

This patent has thirty-one patent family members in twenty countries.

Summary for Patent: 9,555,023

Title:	Pharmaceutical salts and polymorphs of a factor Xa inhibitor
Abstract:	The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making the compound of Formula I. ##STR00001##
Inventor(s):	Grant; Craig (Burwell, GB), Kanter; James P. (San Ramon, CA), Langlands; Graeme (Soham, GB)
Assignee:	Millennium Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:	14/715,507
Patent Claim Types: see list of patent claims	Use; Composition; Dosage form;

Drugs Protected by US Patent 9,555,023

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Portola Pharms Inc	BEVYXXA	betrixaban	CAPSULE;ORAL	208383-001	Jun 23, 2017		DISCN	Yes	No						PROPHYLAXIS OF PULMONARY EMBOLISM
Portola Pharms Inc	BEVYXXA	betrixaban	CAPSULE;ORAL	208383-002	Jun 23, 2017		DISCN	Yes	No						PROPHYLAXIS OF PULMONARY EMBOLISM

International Family Members for US Patent 9,555,023

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	056787
Argentina	106960
Austria	E549317